Alg11 - ALG11, alpha-1,2-mannosyltransferase Gene
Also Known as RGD1564725
Species: Rattus norvegicus
Summary
Predicted to enable GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity. Predicted to be involved in oligosaccharide-lipid intermediate biosynthetic process and protein N-linked glycosylation. Predicted to be integral component of membrane. Predicted to be active in endoplasmic reticulum membrane. Human ortholog(s) of this gene implicated in congenital disorder of glycosylation IP. Orthologous to human ALG11 (ALG11 alpha-1,2-mannosyltransferase). [provided by Alliance of Genome Resources, Apr 2022]
Alg11 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001108401.1 | NP_001101871.1 | GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS00588 | ALG11 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS21478 | Alg11 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27996 | Alg11 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service